We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0QND market cap is 9.51B. The company's latest EPS is CHF 1.4920 and P/E is 84.99.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 313.72M | 402M | 503.23M | 531.74M | 577.32M |
| Operating Income | 62.36M | 96.66M | 128.93M | 127.22M | 129.38M |
| Net Income | 54.16M | 78.06M | 114.68M | 100.68M | 111.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 647.14M | 710.88M | 1.3B | 1.38B | 1.68B |
| Total Liabilities | 199.33M | 235.17M | 177.5M | 214.21M | 362.36M |
| Total Equity | 447.82M | 475.71M | 1.12B | 1.17B | 1.32B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | 64.27M | 115.04M | 97.56M | 92.65M | 249.86M |
| Investing | -30.65M | -69.31M | -469.12M | -63.15M | -170.81M |
| Financing | -34.28M | -43.08M | 437.18M | -87.01M | 48.69M |
| Market Cap | 9.51B |
| Price to Earnings Ratio | 84.99 |
| Price to Sales Ratio | 16.47 |
| Price to Cash Ratio | 60.27 |
| Price to Book Ratio | 7.2 |
| Dividend Yield | - |
| Shares Outstanding | 74.97M |
| Average Volume (1 week) | 5.97k |
| Average Volume (1 Month) | 34.32k |
| 52 Week Change | 0.00% |
| 52 Week High | 126.80 |
| 52 Week Low | 126.80 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bachem Holding Ag |
| Address |
hauptstrasse 144 basel 4416 |
| Website | https://www.bachem.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
